Due to the dose-sensitive role of the amyloid precursor protein (APP) gene, located on chromosome 21 (Chr21), people with Down Syndrome (DS) face an increased risk of developing early-onset AD (EOAD). This evidence concerns the gene APP and Down syndrome.